Literature DB >> 524917

Metabolic studies of ornidazole in the rat, in the dog and in man.

D E Schwartz, J C Jordan, W Vetter, G Oesterhelt.   

Abstract

1. Ornidazole, labelled with 14C in the imidazole ring, administered orally to rats, dogs and men was largely excreted in the urine, predominantly as metabolites, with less than 4% of the drug being excreted unchanged. Free and conjugated metabolites were found in the ratio of approx. 1 : 2. 2. The pattern of free ornidazole and metabolites was different in the three species: while ornidazole predominated in man, ornidazole and metabolite M1 in the dog, the most extensive metabolic pattern was found in the rat. 3. The following metabolites were identified: M1, 1-chlorlo-3-(2-hydroxymethyl-5-nitro-1-imidazolyl)-2-propanol; M2, 2-methyl-5-nitroimidazole; M3, N-(3-chloro-2-hydroxypropyl)acetamide: M4, 3-(-2-methyl-5-nitro-1-imidazolyl)-1, 2-propanediol; M5, acetamide. 4. The formation of metabolite M3 and M5 indicated cleavage of the imidazole ring between N-1/C-5 and C-2/C-3. Other ring scissions were not observed. Metabolites carrying a free amino group were not detected. On the basis of the structures identified, a scheme is suggested for the metabolism of ornidazole.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 524917     DOI: 10.3109/00498257909042323

Source DB:  PubMed          Journal:  Xenobiotica        ISSN: 0049-8254            Impact factor:   1.908


  6 in total

1.  High haemodialysis clearance of ornidazole in the presence of a negligible renal clearance.

Authors:  F F Horber; O Maurer; P J Probst; E Heizmann; F J Frey
Journal:  Eur J Clin Pharmacol       Date:  1989       Impact factor: 2.953

Review 2.  Pharmacokinetics and pharmacodynamics of the nitroimidazole antimicrobials.

Authors:  K C Lamp; C D Freeman; N E Klutman; M K Lacy
Journal:  Clin Pharmacokinet       Date:  1999-05       Impact factor: 6.447

Review 3.  Clinical pharmacokinetics of metronidazole and other nitroimidazole anti-infectives.

Authors:  A H Lau; N P Lam; S C Piscitelli; L Wilkes; L H Danziger
Journal:  Clin Pharmacokinet       Date:  1992-11       Impact factor: 6.447

4.  Pharmacokinetics of ornidazole in patients with renal insufficiency; influence of haemodialysis and peritoneal dialysis.

Authors:  H Merdjan; A Baumelou; B Diquet; O Chick; E Singlas
Journal:  Br J Clin Pharmacol       Date:  1985-02       Impact factor: 4.335

5.  Studies on the disposition of a 5-nitroimidazole in laboratory animals.

Authors:  A Barrow; S R Burford; T J Forrest; A J Hawkins; D A Rose; P M Stevens; C W Vose; C M Walls
Journal:  Eur J Drug Metab Pharmacokinet       Date:  1987 Apr-Jun       Impact factor: 2.441

6.  Developing a genetic manipulation system for the Antarctic archaeon, Halorubrum lacusprofundi: investigating acetamidase gene function.

Authors:  Y Liao; T J Williams; J C Walsh; M Ji; A Poljak; P M G Curmi; I G Duggin; R Cavicchioli
Journal:  Sci Rep       Date:  2016-10-06       Impact factor: 4.379

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.